Vitamin replacement therapy in renal failure patients

Mineral and Electrolyte Metabolism

Volumn 25, Issue 4-6, 1999, Pages 349-351

  Makoff, Rhoda ^a,b  

^a R and D Laboratories Inc   (United States)

^b NONE   (United States)

Author keywords

ESRD; Folic Acid; Homocysteine; Micronutrients; Renal failure; Uremia; Vitamins

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; BIOTIN; CYANOCOBALAMIN; ERYTHROPOIETIN; FOLIC ACID; HOMOCYSTEINE; NICOTINIC ACID; PANTOTHENIC ACID; PYRIDOXINE; RETINOL; RIBOFLAVIN; THIAMINE;

ANEMIA; ASCORBIC ACID DEFICIENCY; CARDIOVASCULAR DISEASE; CONFERENCE PAPER; DIALYSIS; FOLIC ACID DEFICIENCY; HUMAN; HYPERHOMOCYSTEINEMIA; HYPERVITAMINOSIS; KIDNEY FAILURE; PRIORITY JOURNAL; PYRIDOXINE DEFICIENCY; VITAMIN DEFICIENCY; VITAMIN SUPPLEMENTATION;

EID: 0033368376     PISSN: 03780392     EISSN: None     Source Type: Journal    
DOI: 10.1159/000057473     Document Type: Conference Paper

References (22)

1. Rocco M, Makoff R: Appropriate vitamin therapy for dialysis patients. Semin Dial 1997;10: 272-277.
2. Stein G, Sperschneider S, Doppe S: Vitamin levels in chronic renal failure and need for supplementation. Blood Purif 1985;3:52-62.
3. 12 or folic acid absorption or utilization. Am J Med 1970;48:599-608.
4. Drueke TB: Resistance to recombinant human erythropoietin in hemodialysis patients. Am J Nephrol 1990;10(suppl 2):34-39.
5. Hartoff WE, Ridoul JH, Sellers EA, et al: Atheromatous changes in aorta, carotid and coronary arteries of choline deficient rats. Proc Soc Exp Biol Med 1952;81:384-393.
6. Nygård O, Vollset SE, Refsum H, et al: Total plasma homocysteine and cardiovascular risk profile: The Hordaland homocysteine study. JAMA 1995;274:1526-1533.
7. Makoff R, Dwyer J, Rocco MV: Folic acid, pyridoxine, cobalamin and homocysteine and their relationship to cardiovascular disease in endstage renal disease. J Ren Nutr 1996;6:2-11.
8. Hultberg B, Andersson A, Sterner G: Plasma homocysteine in renal failure. Clin Nephrol 1993;40:230-234.
9. Westhuyzen J, Matherson K, Tracey R, Fleming SJ: Effect of withdrawal of folic acid supplementation in maintenance hemodialysis patients. Clin Nephrol 1993;40:96-99.
10. 6 deficiency in uremia. Am J Clin Nutr 1975;28: 950-957.
11. Kopple JD, Mercurio K, Blumenkrantz MJ, et al: Daily requirements for pyridoxine supplementation in chronic renal failure. Kidney Int 1981;19:694-704.
12. 6 requirements of patients on chronic peritoneal dialysis. Kidney Int 1989; 36:702-706.
13. Kelly MP, Kight MA, Don BR, Castillo S, Migliore B: Evaluation of pyridoxal phosphate/B6 status (abstract). J Ren Nutr 1997.
14. Papastephanidis C, Agroyannis B, Tzanatos-Exarchou H, Orthopoulos B, Koutsicos D, Frangos-Plemenos M, Kallitsis M, Yatzidis H: Re-evaluation of ascorbic deficiency in hemodialysed patients. Int Artif Organs 1987;10:163-165.
15. Sullivan JF, Eisenstein AB: Ascorbic acid depletion in patients during hemodialysis. Am J Clin Nutr 1970;23:1339-1346.
16. Thompson CS, Weinman EJ: The secondary oxalosis of renal failure. Semin Dial 1988;1:94-99.
17. Kopple J: Nutrition, diet, and the kidney; in Shills ME, Olson JA, Shike M (eds): Modern Nutrition in Health and Disease, ed 8. Philadelphia, Lea & Febiger Malvern. 1994, pp 1102-1134.
18. Paskalev D, Jankova T, Tschankova P, Steiner M, Nenov D: Increase of plasma and red blood cell vitamin E concentration in uremic patients on maintenance haemodialysis undergoing treatment with recombinant erythropoietin (letter). Nephrol Dial Transplant 1993;8:1187-1188.
19. Muth I: Implications of hypervitaminosis A in chronic renal failure. J Renal Nutrition 1991;1: 2-8.
20. Duffy TP: Remembering the ABC's. N Engl J Med 1994;330:994-996.
21. Pastor MC, Sierra C, Bonal J, Teixido J: Serum and erythrocyte tocopherol in uremic patients: Effect of hemodialysis versus peritoneal dialysis. Am J Nephrol 1993;13:238-243.
22. Ono K: Effects of large dose vitamin E supplementation of anemia in hemodialysis patients. Nephron 1985;40:440-445.